S. Savitha
Research Subjects
S. Savitha has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- R. Keerthana
K.S.R. College of Engineering, India
4 shared publications - K. Logeswaran
Kongu Engineering College
3 shared publications - M. Sangeetha
Dr. N.G.P. Institute of Technology, India
2 shared publications A. Rajivkannan
K.S.R. College of Engineering, India
1 shared publication- Amit Kumar Tyagi
National Forensic Sciences University, Gandhinagar, India
1 shared publication - J. Rameshkumar
K.S.R. College of Engineering, India
1 shared publication
Latest Publications
- 3 April 2026
- Published by IGI Global Scientific Publishing
- p. 383-416
Strengthening E-Collaboration in Healthcare Through AI
Modern healthcare depends on quick diagnoses, secure sharing of medical information, and smooth coordination among hospitals and research institutions. However, traditional computing systems often struggle to manage large and complex clinical data, advanced medical images, and collaboration across multiple organizations. Quantum computing, when combined with e-collaboration platforms, can overcome these challenges by delivering faster analysis, stronger security, and more scalable clinical intelligence. Core quantum principles such as superposition and entanglement—support parallel data processing, rapid optimization, and improved pattern detection in genomics, medical imaging, and continuous patient monitoring. Quantum-enabled backends can strengthen digital collaboration by supporting remote consultations, shared clinical reviews, and coordinated care. Secure communication, privacy-preserving analytics, biomedical simulation, and public-health preparedness are discussed, along with current limitations and future directions.
- 3 April 2026
- Published by IGI Global Scientific Publishing
- p. 383-416
Strengthening E-Collaboration in Healthcare Through AI
Modern healthcare depends on quick diagnoses, secure sharing of medical information, and smooth coordination among hospitals and research institutions. However, traditional computing systems often struggle to manage large and complex clinical data, advanced medical images, and collaboration across multiple organizations. Quantum computing, when combined with e-collaboration platforms, can overcome these challenges by delivering faster analysis, stronger security, and more scalable clinical intelligence. Core quantum principles such as superposition and entanglement—support parallel data processing, rapid optimization, and improved pattern detection in genomics, medical imaging, and continuous patient monitoring. Quantum-enabled backends can strengthen digital collaboration by supporting remote consultations, shared clinical reviews, and coordinated care. Secure communication, privacy-preserving analytics, biomedical simulation, and public-health preparedness are discussed, along with current limitations and future directions.
- 13 May 2025
- Published by IGI Global Scientific Publishing
- p. 107-142
AI Technologies for Predicting Susceptibility and Outcomes of Immunological Disorders
AI improves immune disease prediction by examining clinical and genomic information to determine biomarkers, enhance diagnoses, individualize treatment, and predict outcomes. Challenges include scarce high-quality data, integrating genomic and environmental variables, privacy legislation, bias, and deep learning transparency lowering clinician confidence. Federated learning maintains privacy but grapples with data quality, and explainable AI (XAI) assists interpretability but remains clinically irrelevant. SVMs, RF, CNNs, and RNNs are AI models that help in disease tracking and diagnosis. Clustering and Bayesian networks evaluate risks. Maximizing the potential of AI requires enhancing data quality, model interpretability, and clinician-data scientist collaboration to improve immunological disorder prediction.
- 13 May 2025
- Published by IGI Global Scientific Publishing
- p. 107-142
AI Technologies for Predicting Susceptibility and Outcomes of Immunological Disorders
AI improves immune disease prediction by examining clinical and genomic information to determine biomarkers, enhance diagnoses, individualize treatment, and predict outcomes. Challenges include scarce high-quality data, integrating genomic and environmental variables, privacy legislation, bias, and deep learning transparency lowering clinician confidence. Federated learning maintains privacy but grapples with data quality, and explainable AI (XAI) assists interpretability but remains clinically irrelevant. SVMs, RF, CNNs, and RNNs are AI models that help in disease tracking and diagnosis. Clustering and Bayesian networks evaluate risks. Maximizing the potential of AI requires enhancing data quality, model interpretability, and clinician-data scientist collaboration to improve immunological disorder prediction.
- 23 April 2025
- Published by IGI Global Scientific Publishing
- p. 205-244
Sustainable AI-Powered Systems and Cybersecurity for Health Diagnostics
Artificial intelligence (AI) has transformed early disease diagnosis, providing exceptional speed and accuracy. However, fairness and bias challenges remain in healthcare AI, leading to discriminatory outcomes and worsening existing health inequities. These biases often arise from data imbalances, model architecture, and decision-making processes, with socioeconomic factors exacerbating historical disparities. Curating inclusive datasets with diverse demographic and socioeconomic representation is essential. Techniques like adversarial debiasing and data augmentation improve equity, while algorithmic fairness methods, such as regularization and fairness constraints, ensure equitable treatment. Differential privacy protects sensitive attributes, and ensemble methods like fairness-aware boosting uphold accuracy. Ongoing innovation is crucial for developing transparent, fair, and accurate AI systems in healthcare.
- 23 April 2025
- Published by IGI Global Scientific Publishing
- p. 205-244
Sustainable AI-Powered Systems and Cybersecurity for Health Diagnostics
Artificial intelligence (AI) has transformed early disease diagnosis, providing exceptional speed and accuracy. However, fairness and bias challenges remain in healthcare AI, leading to discriminatory outcomes and worsening existing health inequities. These biases often arise from data imbalances, model architecture, and decision-making processes, with socioeconomic factors exacerbating historical disparities. Curating inclusive datasets with diverse demographic and socioeconomic representation is essential. Techniques like adversarial debiasing and data augmentation improve equity, while algorithmic fairness methods, such as regularization and fairness constraints, ensure equitable treatment. Differential privacy protects sensitive attributes, and ensemble methods like fairness-aware boosting uphold accuracy. Ongoing innovation is crucial for developing transparent, fair, and accurate AI systems in healthcare.
- 21 March 2025
- Published by IGI Global Scientific Publishing
- p. 149-184
Integration of Multi-Omics Data
Integrating multi-omics data, such as proteomics, metabolomics, and genomes, in precision health provides revolutionary insights into biological systems and individualized treatment plans. This chapter focuses on AI-powered techniques for merging multi-omics data, made possible by high-throughput instruments such as next-generation sequencing and mass spectrometry. Single-omic techniques, which frequently overlook intricate molecular interactions essential to comprehending the etiology of disease, are outperformed by multi-omics integration. By capturing non-linear relationships and hierarchical characteristics across genes, proteins, and metabolites, artificial intelligence (AI) techniques—including deep learning models like CNNs and RNNs—increase multi-omics analysis and improve illness treatment and prediction. Federated Multi-Modal Embedding Networks (FMEN) promote precision models across omics types by advancing multi-omics integration through collaborative learning while protecting data privacy.
- 21 March 2025
- Published by IGI Global Scientific Publishing
- p. 149-184
Integration of Multi-Omics Data
Integrating multi-omics data, such as proteomics, metabolomics, and genomes, in precision health provides revolutionary insights into biological systems and individualized treatment plans. This chapter focuses on AI-powered techniques for merging multi-omics data, made possible by high-throughput instruments such as next-generation sequencing and mass spectrometry. Single-omic techniques, which frequently overlook intricate molecular interactions essential to comprehending the etiology of disease, are outperformed by multi-omics integration. By capturing non-linear relationships and hierarchical characteristics across genes, proteins, and metabolites, artificial intelligence (AI) techniques—including deep learning models like CNNs and RNNs—increase multi-omics analysis and improve illness treatment and prediction. Federated Multi-Modal Embedding Networks (FMEN) promote precision models across omics types by advancing multi-omics integration through collaborative learning while protecting data privacy.
- 22 April 2024
- Published by IGI Global Scientific Publishing
- p. 177-189
Emerging Technologies in Drug Discovery for Providing Efficient Services to Patients
This chapter examines the current landscape and future prospects of emerging technologies in drug discovery, focusing on their potential to provide efficient and innovative services to patients. The integration of technologies such as artificial intelligence (AI), machine learning, high-throughput screening, and advanced analytics is reshaping the drug discovery process, promising accelerated development timelines and improved therapeutic outcomes. AI and machine learning algorithms play a pivotal role in data analysis, aiding in the identification of potential drug candidates, target validation, and predictive modeling. High-throughput screening technologies enable the rapid testing of large compound libraries, expediting the identification of lead compounds and optimizing drug development pipelines. Additionally, advanced analytics facilitate the interpretation of complex biological data, enhancing our understanding of disease mechanisms and drug interactions. The convergence of these technologies holds immense promise for personalized medicine.
- 22 April 2024
- Published by IGI Global Scientific Publishing
- p. 177-189
Emerging Technologies in Drug Discovery for Providing Efficient Services to Patients
This chapter examines the current landscape and future prospects of emerging technologies in drug discovery, focusing on their potential to provide efficient and innovative services to patients. The integration of technologies such as artificial intelligence (AI), machine learning, high-throughput screening, and advanced analytics is reshaping the drug discovery process, promising accelerated development timelines and improved therapeutic outcomes. AI and machine learning algorithms play a pivotal role in data analysis, aiding in the identification of potential drug candidates, target validation, and predictive modeling. High-throughput screening technologies enable the rapid testing of large compound libraries, expediting the identification of lead compounds and optimizing drug development pipelines. Additionally, advanced analytics facilitate the interpretation of complex biological data, enhancing our understanding of disease mechanisms and drug interactions. The convergence of these technologies holds immense promise for personalized medicine.